NCT/Study#
NCT03994601 /
CA043-001
A Phase 1/2 First-In-Human Study Of BMS-986288 Alone And In Combination With Nivolumab In Advanced Malignant Tumors
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
